The diversity of Klebsiella pneumoniae surface polysaccharides. by Follador, Rainer et al.
Follador, R; Heinz, E; Wyres, KL; Ellington, MJ; Kowarik, M; Holt,
KE; Thomson, NR (2016) The diversity of Klebsiella pneumoniae
surface polysaccharides. Microbial genomics, 2 (8). e000073. ISSN
2057-5858 DOI: https://doi.org/10.1099/mgen.0.000073
Downloaded from: http://researchonline.lshtm.ac.uk/3716532/
DOI: 10.1099/mgen.0.000073
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
Downloaded from www.microbiologyresearch.org by
IP:  194.80.229.244
On: Wed, 14 Nov 2018 13:19:23
Research Paper
The diversity of Klebsiella pneumoniae surface
polysaccharides
Rainer Follador,1 Eva Heinz,2 Kelly L. Wyres,3,4 Matthew J. Ellington,5 Michael Kowarik,1 Kathryn
E. Holt3,4 and Nicholas R. Thomson2,6
1LimmaTech Biologics AG, Schlieren, Switzerland
2The Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK
3Centre for Systems Genomics, University of Melbourne, Parkville, Victoria, Australia
4Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne,
Parkville, Victoria, Australia
5National Infection Service Public Health England, London, UK
6London School of Hygiene and Tropical Medicine, London, UK
Correspondence: Rainer Follador (rainer.follador@lmtbio.com)
DOI: 10.1099/mgen.0.000073
Klebsiella pneumoniae is considered an urgent health concern due to the emergence of multi-drug-resistant strains for
which vaccination offers a potential remedy. Vaccines based on surface polysaccharides are highly promising but need to
address the high diversity of surface-exposed polysaccharides, synthesized as O-antigens (lipopolysaccharide, LPS) and K-
antigens (capsule polysaccharide, CPS), present in K. pneumoniae. We present a comprehensive and clinically relevant
study of the diversity of O- and K-antigen biosynthesis gene clusters across a global collection of over 500 K. pneumoniae
whole-genome sequences and the seroepidemiology of human isolates from different infection types. Our study defines the
genetic diversity of O- and K-antigen biosynthesis cluster sequences across this collection, identifying sequences for known
serotypes as well as identifying novel LPS and CPS gene clusters found in circulating contemporary isolates. Serotypes O1,
O2 and O3 were most prevalent in our sample set, accounting for approximately 80 % of all infections. In contrast, K sero-
types showed an order of magnitude higher diversity and differ among infection types. In addition we investigated a potential
association of O or K serotypes with phylogenetic lineage, infection type and the presence of known virulence genes. K1
and K2 serotypes, which are associated with hypervirulent K. pneumoniae, were associated with a higher abundance of viru-
lence genes and more diverse O serotypes compared to other common K serotypes.
Keywords: Klebsiella pneumoniae; seroepidemiology; surface polysaccharide; K antigen and O antigen; vaccine target.
Abbreviations: CPS, capsule polysaccharide; ESBL, extended spectrum beta lactamases; MLST, multilocus sequence
typing; TPP, thiamine pyrophosphate; UndPP, undecaprenyl-pyrophosphate; LPS, Lipopolysaccharide.
Data statement: All supporting data, code and protocols have been provided within the article or through supplementary
data files.
Data summary
Supplementary dataset S1 lists the ENA accession numbers
for the 573 publicly available K. pneumoniae whole-genome
Illumina read sets analysed in this study (http://www.ebi.ac.
uk/ena).
Representative rfb and cps locus sequences have been depos-
ited in GenBank, see Table S2 for the list of GenBank acces-
sion numbers (http://www.ncbi.nlm.nih.gov/genbank/).
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Introduction
Klebsiella pneumoniae is a leading cause of hospital- and
community-acquired infections (including urinary tract
infections, pneumonia, bacteraemia and soft tissue infec-
tions), primarily afflicting the young and immunocompro-
mised, despite being part of the normal human intestinal
microbiota and able to colonize the skin and nasopharynx
of healthy individuals (Podschun & Ullmann 1998; Bro-
berg et al. 2014). K. pneumoniae are naturally resistant to
antibiotics such as amino-penicillins and carboxy-penicil-
lins. Increasingly, treatment options are diminishing, leav-
ing third-generation cephalosporins and carbapenems as
the remaining alternative. However, the emergence of iso-
lates carrying genes encoding extended spectrum beta lac-
tamases (ESBL) and carbapenemases has raised alarm
because it removes these last line treatment options and
effectively negates the use of a whole class of antibiotics,
with few alternatives. Therefore multiple agencies including
the WHO, US Centers for Disease Control and Prevention
and the UK Department of Health singled out K. pneumo-
niae as a global health concern (Boucher et al. 2009;
Ahmad et al. 2012).
Historically Klebsiella isolates have been classified into sero-
types and tracked using typing antisera. Serotyping is based
on the recognition of distinct variations of surface-exposed
polysaccharides, namely O-antigens and K-antigens, by spe-
cific antibodies, resulting in different O and K serotypes. O-
antigens are the outermost part of the lipopolysaccharide
(LPS), whereas K-antigens belong to the bacterial capsule
polysaccharide (CPS). The number of serotypes has been
estimated to be eight for O-antigens and 77 for K-antigens
(Orskov, Fife-Asbury 1977; Trautmann et al. 1997;
Edwards, Fife 1952; Edmunds 1954).
Multivalent protein-conjugate polysaccharide vaccines have
been demonstrated to be highly successful and effective
against bacterial pathogens, such as Streptococcus pneumo-
niae (Center, 2007). In K. pneumoniae, polyvalent vaccines
based on the K-antigen have been developed and reached
Phase I trials in humans (Edelman et al. 1994; Campbell
et al. 1996). However, the high diversity of K-antigens and
the confusing seroepidemiology render a vaccine with a
broad coverage complex to develop and thus very costly.
Compared with other Enterobacteriaceae, such as Escherichia
coli [161 defined O serotypes (Iguchi et al. 2015a)] and Shi-
gella flexneri [at least 47 O serotypes (Talukder et al. 2003)],
Klebsiella has a surprisingly low number of reported O sero-
types which promises a more viable alternative for vaccine
development compared with K-antigen-based vaccines
(Ahmad et al. 2012). Whole-genome sequence data allows
us to verify and assess the diversity of these clusters and also
estimate their frequency in contemporary isolates to assess
the contribution of isolates bearing these markers.
The O-antigen biosynthesis enzymes are encoded on the rfb
locus. To date, seven O-antigen clusters have been defined
for K. pneumoniae, associated to serotypes O1, O2, O3, O4,
O5, O8 and O12 (Table S1) and the rfb O-antigen
biosynthetic pathway is well described (Raetz & Whitfield,
2002; Kalynych et al. 2014; Whitfield & Trent 2014). In
essence it is an ABC-transporter-dependent pathway func-
tionally composed of three types of enzymes: those respon-
sible for (i) biosynthesis of nucleotide-activated sugars, (ii)
polysaccharide repeat-unit synthesis and (iii) assembly of
the repeat units and transport across the membrane
(flippases).
Both the O1 and O2 antigen polysaccharide chains are
based on a repeat-unit designated as D-galactan I. The differ-
ence being that the O1 antigen is capped by a distal D-galac-
tan II unit, whereas O2 is not (Vinogradov et al. 2002; Kol
et al. 1992). D-galactan II is the only known O-antigen poly-
saccharide in Klebsiella for which biosynthesis is enabled by
genes (wbbY and wbbZ) unlinked to the rfb cluster (Hsieh
et al. 2014). The O1/O2 biosynthetic cluster occurs in two
variants (Fig. 1a). Variant 1 consists of the transporter genes
(wzm and wzt), three glycosyltransferases responsible for
repeat-unit synthesis and an UDP-galactopyranose mutase,
responsible for the synthesis of the polysaccharide subunit
D-galactan I (Clarke & Whitfield 1992). Variant 2 is
extended and carries three additional putative glycosyltrans-
ferases encoded by gmlABC. These additional genes are
thought to explain the existence of a recently defined O2
subtype whereby the gml gene products modify D-galactan I,
to give the chemically and antigenically distinct D-galactan
III explaining the different subtype (Kelly et al. 1995; Szi-
jártó et al. 2015). The serology of O1 isolates is proposed to
be unchanged by GmlABC, because in this instance D-galac-
tan II (encoded by WbbY and WbbZ) is the dominant anti-
genic epitope (Szijártó et al. 2015).
O-antigen polysaccharide structure and rfb sequence of K.
pneumoniae serotypes O3 and O5 are identical to those of E.
coli serotypes O9a and O8, respectively (Vinogradov et al.
2002; Iguchi et al. 2015b). Biosynthesis enzymes of O3 and
O5 differ in the sequence of their mannosyltransferase
(WbdA) and methyltransferase (WbdD). WbdD, in com-
plex with WbdA, regulates the mannose chain length by
capping the growing chain with a phosphate and methyl
Impact statement
Vaccines offer a potential remedy against the increas-
ing threat of pan-drug-resistant Klebsiella pneumo-
niae strains. However the high diversity of surface
antigens poses a challenge for vaccine design. This
work is the first, to our knowledge, to catalogue nat-
urally occurring polysaccharide antigen biosynthesis
gene clusters in a globally representative collection of
K. pneumoniae isolates, enabling us to identify novel
serotypes and perform an epidemiological analysis.
We show that only three O-antigen serotypes
account for the majority of infections, offering a
promising target for vaccine design.
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group in O3 and a methyl group only in O5 (Hagelueken
et al. 2012, 2015).
For completeness the O8 polymer is identical to the O1 anti-
gen, with the exception of the partial O-acetylation of the D-
galactan I repeat unit in O8 (Kelly et al. 1993) and serotype O9
may be considered as a subtype of serogroup O2 (Hansen
et al. 1999; Trautmann et al. 1997; Kelly & Whitfield 1996).
Serotype O9 Wzm and Wzt sequences share >95 % identity
to the O8Wzm andWzt orthologues (Fang et al. 2015)
Whilst most members of the Enterobacteriaceae have one
conserved LPS core, two types of outer cores have been
reported for K. pneumoniae; they differ in a set of three
genes within the waa operon (Regué et al. 2005), which is
independently located in the genome.
The seroepidemiology of K. pneumoniae has previously
shown that for human-host-associated isolates the most
prevalent O serotypes are O1, O2 and O3, with O1 being
dominant in human disease (Trautmann et al. 1997;
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Fig. 1. (a) rfb gene clusters (see Fig. S1 , available in the online Supplementary Material for full list), genes are colored according to func-
tion (see Fig. S1) and above or below the line according to the coding strand and the direction of transcription (black arrows). (b) WbdD
sequence alignment. Comparison of E. coli 09a (Uniprot accession number Q47592) and one representative each for the two types of K.
pneumoniae O3 WbdD (O3 long (isolate 5151_3#1) and O3 short (9878_1#12)) and OL104 wbdD (5193_7#2). The alignment was col-
ored according to the BLOSUM62 score. Domain detection was performed using InterProScan5 (Jones et al. 2014) based on the E. coli
WbdD sequence.
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Hansen et al. 1999; Yu et al. 2007; Fang et al. 2015). The
observed prevalence of O4, O5 and O12 differs among the
studies, whereas the significance of serotypes O8 and O11
remain equivocal (Trautmann et al. 1997). For O11 this is
due to the lack of available rfb sequences and publicly avail-
able O11 isolates, so they could not be considered in this
study. In addition, little is known about the association
between O serotype and disease presentation, the only
exception being the observation that serotype O3 isolates
are more commonly isolated from blood samples compared
with urine samples (Trautmann et al. 1997; Hansen et al.
1999).
The K-antigen biosynthesis enzymes are encoded on the cps
(capsule polysaccharide synthesis) locus. To date the cps
gene clusters of the 77 serologically defined K-types and
nine additional distinct cps operons have been identified
and published (Pan et al. 2015; Chung The et al. 2015;
Wyres et al. 2015). The biosynthesis pathway is a Wzy-
dependent polymerization pathway, identical to E. coli
Group 1 capsule synthesis (Whitfield 2006; Larue et al.
2009; Shu et al. 2009; Bushell et al. 2013).
There is some confusion in the literature regarding the prev-
alence of K serotypes and their association with disease out-
come (Cryz et al. 1986; Fung et al. 2000, 2002; Yu et al.
2007). This may be explained by the higher diversity of the
K serotypes and possible cross-reactivity, making them
much harder to define. In some studies K1 and K2 showed
the highest prevalence and were associated with poorer dis-
ease outcome (Fung et al. 2000, 2002; Yu et al. 2007). In
addition, these K serotypes have been associated with the
emergence of hypervirulent K. pneumoniae causing commu-
nity-acquired invasive infections such as pyogenic liver
abscess, which has become of particular concern in parts of
Asia (Shon et al. 2013). Hypervirulent K1 strains generally
belong to the ST23 lineage, while K2 is found in more
diverse backgrounds (Struve et al. 2015; Bialek-Davenet
et al. 2014). However, in many studies outside of Asia,
including an extensive seroepidemiological study of Euro-
pean and North American cases, K1 isolates are rare (Cryz
et al. 1986).
Until now our knowledge of the nature and diversity of O-
and K- operons and, by proxy, the antigens they encode is
based on sequences of a limited number of reference iso-
lates. Recently, the whole-genome sequences of more than
500 isolates collected from environmental samples, plants,
mammals and non-human primates, as well as those from
asymptomatic human carriage, from cases of invasive dis-
ease and from both the clinical and community setting were
sequenced and published (Holt et al. 2015; Ellington, 2016;
Chung The et al. 2015; Wand et al. 2015) (Table 1). These
studies highlighted that the ability to cause invasive infec-
tions is not determined by lineage but is associated with the
presence of virulence factors such as siderophore systems
and the rmpA mucosity factor, although these virulence
determinants are overrepresented in lineages associated
with the hypervirulence phenotype (Holt et al. 2015; Bialek-
Davenet et al. 2014; Struve et al. 2015).
Using this comprehensive whole genome dataset we set out
to describe the genetic diversity of O-antigen and K-antigen
and LPS core biosynthesis gene clusters and classify them by
molecular serotyping. Using these data we then set out to
determine if there was an association between O-, K- or
LPS core types and disease outcome, phylogenetic lineage or
the presence of other known virulence-related genes.
Methods
Bacterial isolates. Publicly available genome data derived
from four different K. pneumoniae collections were analyzed
in this study, totaling 573 sequenced isolates (Table 1). The
global dataset consists of a globally representative collection
from six different countries including isolates from different
hosts and different infection types (Holt et al. 2015). The
UK hospital dataset consists of a collection from the Cam-
bridge University Hospitals NHS Foundation Trust and
contains invasive isolates biased towards those with resis-
tance to third-generation cephalosporins collected over a
period of seven years (Ellington 2016). The Nepal hospital
dataset contains human isolates from a single Nepalese hos-
pital outbreak in 2012 (Chung The et al. 2015). The preanti-
biotic dataset contains strains isolated before the widespread
use of antibiotics (pre 1949) (Wand et al. 2015).
Genome data, generated in the above studies by paired end
Illumina sequencing, were sourced from the European
Nucleotide Archive (accession numbers are listed in Supple-
mentary dataset S1, available in the online supplementary
material). Reads were de novo assembled using Velvet (Zer-
bino & Birney 2008) and Velvet Optimiser, and the result-
ing assemblies annotated using Prokka (Seemann 2014), as
described previously (Holt et al. 2015).
In silico serotyping. O serotyping was performed on the
basis of the polysaccharide ABC transporters (flippases;
Wzm and Wzt). The specificity of transporters to polysac-
charide types has been noted previously (Cuthbertson et al.
2007). The protein sequences of Wzm were located and
extracted from the assembled and annotated contigs using
tblastn (Camacho et al. 2009) and grouped based on
sequence clustering using CD-HIT (Fu et al. 2012) with an
identity threshold of 95 %. This threshold was empirically
derived and shown to be able to differentiate between the
previously described rfb clusters (Table S1. The resulting
groups were assigned the O serotype of known Wzm
sequences (Table S1), which were included in the clustering
step. In cases where Wzm was missing, Wzt homology was
used for assignment. Any rfb loci which differed from previ-
ously described loci in their sequence and gene content
were assigned to putative novel O serotypes. Novel rfb loci
sequences were given the designation OL[n], etc, (OL=LPS
locus, to differentiate those defined on the basis of rfb locus
sequences from those defined serologically; n is a numeric
identifier beginning from n=100) (Fig. S1, Table S2). The
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differentiation of O1 from O2 serotypes was based on the
presence of WbbY and WbbZ in O1 (NCBI accession num-
ber KJ451390, strain NTUH-K2044 (Hsieh et al. 2014)).
LPS core types were assigned as described above, using
WaaL clustering with an identity threshold of 80 %. The
waa gene cluster was extracted by locating WaaC and
WabG using tblastn. Several operons contained a contig
break or stretches of low sequencing coverage; when no
waaL could be identified or did not fit into any of the two
main groups, these were marked as unassigned.
Due to the much higher diversity of the K antigen, grouping
was performed based on the full-length cps sequence, which
was extracted by locating wzi and wzc using tblastn (Cama-
cho et al. 2009) and extending the presumed locus until a
gene on the opposite strand appeared. The extracted cps
locus DNA sequences were grouped using UCLUST (Edgar
2010) based on a 95 % identity. The groups were assigned
to a serotype if they matched to any of the 86 previously
described cps locus sequences (Pan et al. 2015; Chung The
et al. 2015; Wyres et al. 2015).
Additionally, a database of wzi (Brisse et al. 2013) and wzc
(Pan et al. 2013) sequences with known serotypes was used
to verify the classifications. Any cps clusters which differed
from previously described loci in their sequence and gene
content were assigned to putative novel K serotypes. Puta-
tive full-length novel clusters were confirmed by generation
of alternative assemblies using SPAdes 3.6.1 (Bankevich
et al. 2012) and inspection of the resulting assembly graph
using Bandage (Wick et al. 2015). Sequences were con-
firmed as full length if they spanned from the 5¢ galF to the
3¢ ugd gene. Full-length clusters were given the designation
KL[n], etc: KL=capsule locus, to differentiate those defined
on the basis of cps locus sequences from those defined sero-
logically; n is a numeric identifier beginning from n=101
(although the first two loci (KL101 and KL102) have already
been named KN1 and KN2 in the literature, and thus we
will continue to use these designations here). Representative
nucleotide sequences of full length cps and rfb clusters were
annotated using Prokka (Seemann 2014) followed by man-
ual curation, and deposited in GenBank (Fig. S1, Table S2).
Novel wzi alleles were added to the K. pneumoniae whole-
genome sequence typing database BIGSdb at the Institut
Pasteur (http://bigsdb.web.pasteur.fr/) (Bialek-Davenet
et al. 2014).
Seroepidemiology of human K. pneumoniae infections.
To analyze the prevalence of different O and K serotypes in
human disease and their putative association with disease
outcome, the 216 human-associated isolates of the global
collection were used to investigate their seroepidemiology.
Three different infection properties were examined for asso-
ciation between O and K serotypes and LPS core variant: (i)
infection site: we focused on isolates sampled from human
blood (representing bacteraemia), sputum (pneumonia)
and urine (urinal tract infections, UTI), isolates from other
sites were excluded from this category, (ii) acquisition type:
hospital-acquired isolates had been sampled in patients
from 48 h after admission to hospital, community-acquired
isolates had been sampled within 48 h of admission to hos-
pital, isolates where no acquisition type was recorded were
excluded from this category, (iii) infection status: carriage
isolates are intestinal samples without any infection, non-
invasive isolates are infections without bacteraemia (such as
wound infection, pneumonia, UTI) and invasive isolates are
from infections of normally sterile sites (such as blood).
Table 1. Genome data included in this study and references
Dataset Note Reference
Global 289 isolates; Human and environmental isolates, from six countries (Australia, Indonesia, Laos, Singapore,
Vietnam, USA), sampled to maximize diversity and exclude members of a clonal outbreak, metadata
includes invasiveness, acquisition type and sample site.
Invasiveness status of human isolates consists of three types: carriage (isolates not considered to be the
cause of an infection), non-invasive (pneumonia, urinary tract infection, wound infection; with no
recorded bacteraemia) and invasive (isolated from normally sterile sites: blood, CSF, intra-ocular, pleural,
pericardial, joint fluids, deep-seated tissue abscesses). Acquisition type is either community acquisition
(isolated within 48 hours of admission to hospital) or hospital acquisition (isolated after 48 hours after
admission)
(Holt et al. 2015)
UK Hospital 162 isolates; Collection from Cambridge University Hospitals NHS Foundation Trust in the UK over a
period of seven years, invasive isolates isolated from normally sterile sites. Biased selection for
antimicrobial resistance to three or more of six antimicrobial classes (penicillins, amoxacillin-clavulanate,
aminoglycosides, fluoroquinolones, trimethoprim and third-generation cephalosporins), metadata
includes sample site
(Ellington 2016)
Nepal
Hospital
88 isolates; Nepalese hospital outbreak from May to December 2012, consisting mainly of two clonal
lineages; randomly selected blood cultures.
(Chung The et al.
2015)
Preantibiotic 34 isolates; Collection of isolates isolated before the widespread use of antibiotics (pre 1949). No additional
metadata available.
(Wand et al.
2015)
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Gene presence. A database of putative virulence genes was
compiled (Table S3) and the presence of these genes was char-
acterized as described previously (Chung The et al. 2015).
Multi locus sequence typing (MLST). MLST sequence
types for all isolates were determined directly from
sequence reads using SRST2 (Inouye et al. 2014) to type
against the seven-locus MLST scheme (Diancourt et al.
2005). Sequence types (ST) are listed in Supplementary
dataset S1.
Comparative gene analysis and phylogenetic trees.
Comparative gene analysis and core genome definition was
performed using Roary (Page et al. 2015), using a blastp
percentage identity of 95 % and a core definition of 99 %.
Phylogenies were inferred from either a SNP alignment gen-
erated by mapping reads to the K. pneumoniae MGH78578
reference sequence (Fig. S2) or from a concatenated align-
ment of core genes extracted from Roary output (Page et al.
2015) (Fig. 2). Single-gene alignments (Fig. 1b and Fig. S3)
were performed using Clustal Omega (Sievers et al. 2011).
Phylogenies were inferred from these alignments by running
RAxML using a gamma distribution to model site-specific
rate variation and 100 bootstrap replicates (Stamatakis
2006).
Results
Genetic structures of the rfb gene cluster
The rfb gene cluster was located from the genome sequence
data and classified on the basis of Wzm and Wzt protein
sequence. The rfb cluster was universally located between
the cps and his gene clusters in all of our samples (Fig. S1).
It was evident from these data that there were rfb operons
that did not match any of the known rfb gene clusters (i.e.
they did not belong to O1, O2, O3, O4, O5, O8 or O12),
either as a result of different gene content or differing nucle-
otide sequence. These clusters were defined as novel geno-/
serotypes. Out of the 573 isolates analyzed in this study, 533
isolates could be assigned to six known O serotypes, 36 iso-
lates to five novel serotypes, and four isolates remain unas-
signed due to contig breaks or missing sequencing coverage
(Supplementary dataset S1).
The clusters themselves range in size from seven to ten
genes (8–10 kb). Both O1/O2 variants, O3, O4, O5 and
O12, and four novel rfb clusters (OL101, OL102, OL103
and OL104) were observed in our dataset (Fig. 1a). The
novel cluster, OL104, is identical in gene repertoire to O3
and O5, both synthesizing a mannose polymer repeated
subunit. OL104 possesses the same WbdA as O3, that con-
tains two mannosyltransferase domains and is distinct from
the longer O5 WbdA, that contains three mannosyltransfer-
ase domains, which have been shown to have functional
consequences in the mannosyl linkages they are able to syn-
thesize (Greenfield et al. 2012). Within the isolates desig-
nated as serotype O3, two types of WbdD, the chain-length
regulator, were observed. One (present in 34 of a total of 86
O3 isolates screened; 40 %) is identical to the E. coli O9a
WbdD (Uniprot accession number Q47592), whereas the
other type (present in the remaining 52 isolates; 60 %) has
a deletion of 25 aa at the C-terminal region of its protein
kinase domain. The WbdD of the isolates designated as
serotype OL104 shows the same deletion (Fig. 1b). We spec-
ulate that OL104 and the two O3 WbdD variants might
actually represent serologically distinct subtypes of the O3
serogroup.
The K. pneumoniae O12 antigen is composed of an N-ace-
tylglucosamine and rhamnose polymer (Vinogradov et al.
2002). Based on their gene content and order, O12, OL101
and OL102 are also closely related rfb clusters differing by
the presence and absence of single genes: Compared with
the O12 cluster, OL101 includes an additional glycosylhy-
drolase located on the opposite strand, while OL102 lacks
the terminal glycosyltransferase gene but possesses an addi-
tional rhamnan synthesis gene (Fig. 1a).
It is of note that the direction of transcription in all of the
rfb operons run antiparallel to those genes belonging to the
adjoining his operon, with exception noted above, the O4
cluster and the extended variant of the O1/O2 O-antigen
cluster (O1/O2 Variant 2) (Fig. 1a). The O4 rfb cluster is
the only rfb cluster in K. pneumoniae containing a transpo-
sase. The O4 antigen is based on a galactose and ribofura-
nose polymer (Vinogradov et al. 2002).
When assessing the genetic diversity of the waa LPS core
biosynthesis operon we detected both of the known core
types, but found no conclusive evidence for novel core
types.
Genetic structures of the cps gene cluster
The cps gene cluster showed a strikingly higher level of
diversity both in sequence and gene content, compared to
the rfb clusters (Fig. S1). Clusters ranged in size from
20.5 to 21.6 kb.
Of the 573 isolates analyzed, 387 (68 %) were assigned to
52 known K serotypes by comparison to previously
described cps clusters representing the serologically typed
reference strains (Pan et al. 2015) (Supplementary dataset
S1). Three isolates (0.5 %) where only a partial sequence
was available were assigned to a serotype with lower confi-
dence due to only a partial match to the reference sequence.
A total of 165 isolates (29 %) for which the cps sequence
was >5 % different to those of any of the known cps clusters
were putatively assigned to 68 novel serotypes. Eighteen iso-
lates (3 %) remained unassigned because no wzi and wzc
sequences could be identified in the genomes. Among the
putative novel serotypes, 21 distinct full-length cps sequen-
ces were identified (Fig. S1). Five of these sequences
matched or were transposase variants of those previously
described in (Wyres et al. 2015) and (Chung The et al.
2015), including one which was a transposase-negative
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Australia
Indonesia
Laos
Nepal
Preantibiotic Collection
Singapore
UK
USA
Vietnam
O serotype
K serotype
Origin
Type 1 core
Unassigned or missing
Type 2 core
LPS core type
9221_7#90
5150_1#8
5193_1#10
9221_7#19
5151_5#9
5151_3#8
5151_3#1
9221_7#18
9663_8#8
5151_2#7
9716_2#87
5150_1#7
5150_3#8
5299_1#5
9663_8#33
9664_8#4
5235_5#1
5150_2#1
9221_7#38
10315_6#47
5197_2#5
5193_6#1
5193_3#11
5193_7#8
9221_7#53
5235_5#10
5235_2#4
5193_3#12
5235_1#6
5193_3#7
5150_3#2
5193_6#10
5193_8#12
5235_8#9
5235_2#7
5235_7#3
9803_5#57
5235_5#8
5235_3#7
5193_5#12
9663_8#49
9221_7#30
5193_6#2
5197_2#6
5193_7#3
9664_8#1
5299_1#2
5235_2#5
5235_7#5
5235_8#7
5193_6#11
5193_6#12
9663_7#18
9663_8#76
5235_6#3
5235_8#5
5197_8#9
5193_7#11
5150_5#1
5193_6#6
5151_3#10
9221_7#55
5235_1#11
5299_1#7
10315_6#39
9664_8#13
10315_6#58
5299_7#1
5151_6#9
5235_5#11
5151_2#8
5299_7#3
9221_7#85
5235_1#5
5235_8#4
9221_7#89
5197_8#7
5150_3#7
10315_6#1
10315_6#52
5235_8#8
10315_6#38
5193_3#6
9221_7#3
9221_7#27
9221_7#81
9221_7#28
9221_7#21
9221_7#11
9663_8#25
9221_7#17
9221_7#10
9221_7#50
5151_6#6
5193_2#6
5299_7#6
5150_5#4
5193_3#5
9663_7#72
5193_2#11
5151_5#8
5151_5#5
5151_5#12
9663_8#79
5235_5#2
5193_2#7
10315_6#72
9221_7#69
5151_3#5
5235_6#12
9221_7#82
5151_6#11
5151_3#6
5197_8#4
9663_8#83
5235_1#10
5193_3#8
9716_2#6
10315_6#41
9663_7#48
9663_7#65
9663_8#24
9663_8#44
9663_8#66
5197_8#1
10315_6#22
10315_6#88
5193_2#2
5193_8#1
5193_8#3
5193_8#10
5193_8#6
5151_6#2
5235_1#12
9664_8#10
5150_1#10
10356_5#81
5235_8#3
9664_8#11
9221_7#47
5197_8#2
9664_8#12
9664_8#3
5193_5#1
10315_6#70
5299_7#4
9221_7#20
5150_2#4
10315_6#54
5235_2#1
5299_1#10
5235_6#10
9663_8#74
5235_3#9
9663_8#84
9221_7#1
5150_1#9
9663_7#9
5193_6#7
10356_5#79
5150_5#10
9878_1#11
10356_5#82
10315_6#68
10315_6#92
10356_5#80
10315_6#89
10315_6#93
10315_6#49
10315_6#67
5150_2#6
5150_1#2
9663_7#8
10315_6#69
9221_7#43
9663_7#73
5235_2#8
5235_2#6
9221_7#71
5235_2#2
9663_8#51
5151_5#3
5193_6#8
5151_2#6
5197_7#6
5151_5#1
9663_7#21
9221_7#59
5193_2#5
5151_2#4
9221_7#68
5193_1#4
5235_8#2
5151_2#1
5150_3#1
5235_6#8
5193_1#6
5193_1#8
5197_7#3
10315_6#85
5151_6#1
9776_2#43
9471_7#64
9776_2#51
8939_4#18
9471_7#43
9776_2#45
5151_3#11
9471_7#11
8939_4#27
8939_4#34
9776_2#24
9776_2#31
9776_2#30
8939_4#26
9471_7#15
9776_2#46
9776_2#27
8939_4#62
9471_7#66
9471_7#54
5150_2#12
5235_6#9
5193_5#10
5235_5#6
9221_7#39
9221_7#63
5150_2#7
5151_6#3
5150_3#9
5299_7#10
5193_7#9
9663_7#14
9663_8#41
5193_1#5
5193_1#11
5235_5#4
5235_8#6
5235_6#11
9663_8#55
5193_3#10
5150_3#3
5235_7#2
5235_7#11
5235_7#10
9221_7#12
9221_7#13
9221_7#67
9221_7#36
9221_7#76
9221_7#44
9221_7#86
9221_7#77
9221_7#79
9221_7#72
9221_7#64
9716_2#16
5235_3#8
9663_8#81
5235_5#5
5235_6#1
5193_6#9
5193_6#5
10315_6#24
5197_7#2
5197_8#8
10315_6#10
5150_2#11
5150_2#10
5299_7#2
5235_1#8
9663_7#47
9663_7#23
5299_7#8
10315_6#29
9221_7#48
10315_6#28
9221_7#51
10315_6#62
9663_8#39
5193_8#8
9221_7#87
10315_6#73
10315_6#11
10356_5#77
10315_6#20
10315_6#82
10315_6#79
10315_6#2
10315_6#5
10315_6#8
10315_6#80
10315_6#18
9878_1#3
9878_1#5
9878_1#4
KpIII
KpII
KpI
Fig. 2. Phylogeny of a randomly selected subset of isolates. Lineages are labeled according to the scheme of (Holt et al. 2015), subdivid-
ing the K. pneumoniae species into subspecies KpI (K. pneumoniae), KpII (K. quasipneumoniae) and KpIII (K. variicola). O and K serotypes
and LPS core types, as well as the geographical origin, are denoted by colored squares as indicated.
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variant of the cps cluster from K. pneumoniae HS11286
(genome accession NC_016845.1).
Consistent with results from previous studies, the first gene
in all cps clusters was galF (Ebrecht et al. 2015) followed by
a putative glucose phosphatase (cpsACP), the JUMPstart
sequence (‘just upstream of many polysaccharide starts’)
followed by the translocation and surface assembly genes
(wzi, wza, wzb and wzc) (Rahn et al., 1999). Although the
genes responsible for transport into the periplasm and poly-
merization (wzx and wzy), UndPP-linkage (wbaP or wcaJ)
and a 6-phosphogluconate dehydrogenase [gnd, a house-
keeping gene not required for CPS synthesis (Chen et al.
2010)] were universally present, they were not found at
fixed locations in these clusters. The cps clusters are usually
terminated by UDP-glucose 6-dehydrogenase gene (ugd).
The gene encoding glucose dehydratase (rffG) separates the
cps and rfb clusters.
The distribution of the rfb and cps gene clusters
across K. pneumoniae phylogeny
To understand the distribution of the rfb, cps and waa gene
clusters across the K. pneumoniae species we reconstructed a
whole-genome-based phylogeny for all isolates included in
this study and show their distribution (Fig. 2). This high-
lights that, with some exceptions, rfb clusters are not
restricted to any particular clade. In our dataset the O1 and
O2 rfb loci are only found in the KpI sublineage (K. pneu-
moniae sensu stricto (Holt et al. 2015)), for the other rfb
clusters there is extensive evidence of horizontal gene trans-
fer of the different rfb clusters between closely and more dis-
tantly related lineages. This is further confirmed by the
non-concordance of the phylogeny of the rfb gene clusters
and the whole-genome phylogeny [O1 and O2: Fig. S2(a);
O3, O5 and Novel 4: Fig. S2(b)].
The two waa LPS core types are equally not restricted to
particular clades in the phylogeny, although we note a
biased distribution with respect to the O serotypes. Out of
the 573 isolates in the full dataset, 70 isolates (12 %)
encoded core type 2; these core 2 strains are almost exclu-
sively (65 isolates, 93 %) associated with serotype O1. The
remaining isolates are core 1 (446, 78 %) or unassigned (57,
10 %). One previous study (Regué et al. 2005) investigated
the distribution of LPS core types in 100 K. pneumoniae
strains based on PCR and dot blots and found a ratio of LPS
core 1 to LPS core 2 isolates similar to our data (79 : 19),
and also noted the association of LPS core 2 with serotype
O1 (10 out of 34 O1 strains); however we did not observe
an association with K serotype K2 as has been previously
reported. Our analysis shows an elevated number of strains
carrying both the LPS core type 2 and K2 or K45, however
this is likely to be strongly influenced by two clonal expan-
sions within the sample collection we analysed (Fig. 2). Fur-
thermore, we could only observe LPS core type 2 in
subspecies KpI (Fig. 2).
Due to the high diversity, K serotype switching is more diffi-
cult to analyze. As an example, K1 isolates belong mainly to
two lineages, one of which (ST23) is associated with the
hypervirulent phenotype, whereas the K2 serotype is much
more distributed across the phylogenetic tree, including lin-
eages associated with the hypervirulent phenotype (e.g.
ST25) and other non-hypervirulent lineages (e.g. ST14,
Fig. 2). This is consistent with previous reports which
showed that many K. pneumoniae sequence types include
multiple CPS types (Wyres et al. 2015; Holt et al. 2015;
Brisse et al. 2009).
O and K Serotype epidemiology
Looking across the full dataset of the 573 isolates the major-
ity were genotyped as O1 (296 isolates, 52 %), followed by
O2 (91, 16 %), O3 (86, 15 %), O5 (33, 6 %), OL101 (26,
5 %), O4 (18, 3 %) and O12 (9, 2 %). Each of the OL102
to OL104 serotypes occur in less than 1 % of isolates. The
O1/O2 extended rfb cluster variant 2 was observed in 112
(38 %) of O1 genotyped isolates and 52 (57 %) O2 isolates
(Supplementary dataset S1).
The seven most common O serotypes described above were
associated with 54, 39, 40, 22, 14, 7 and 9 distinct K sero-
types respectively, suggesting there is a relationship between
the number of representatives of each O serotype in our
dataset and the number of distinct K serotypes with which
each is associated. This relationship is best explored using
only the global isolate set, which is not biased towards any
particular K. pneumoniae lineage or isolate source. Within
this dataset O1 is the most common O serotype (n=133)
and was associated with 43 distinct K serotypes. O3 is the
next most common O serotype (n=45), followed by O2
(n=39) and O5 (n=24), these were associated with 29, 30
and 20 distinct K serotypes, respectively. Among the same
isolate set the most common K serotype was K2 (n=20),
associated with two distinct O serotypes (O1 and O2). K1
(n=15) and K64 (n=14) are the next most common sero-
types and are associated with two and four O serotypes
respectively. All other K serotypes are represented by eight
or fewer isolates in our collection and were each associated
with just one or two distinct O serotypes. These data
indicate that re-assortment of K and O types occurs fre-
quently in K. pneumoniae.
To investigate the seroepidemiology in human disease, we
analyzed the association of O and K serotypes with the three
different recorded infection properties (infection site, acqui-
sition type and infection status), using the human-associ-
ated isolates of the global collection (Table 2, Fig. 3).
Fisher’s exact test was performed to examine whether there
was a significant association between serotypes or LPS core
types and infection sites, acquisition type or infection status.
Significant correlations were found between K2 and invasive
infections (odds ratio 4.1, p=0.008), and between OL101 O
type and asymptomatic carriage (OR 8.5, p=0.009)
(Table 2). Of special interest is also K1, which was virtually
restricted to community-acquired isolates (OR 8.4,
p=0.016) and completely missing in carriage-associated iso-
lates (p=0.024). No correlation was found for any
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association of either O or K serotype to infection sites and
no correlation of LPS core type with any of the traits as
above was observed.
To assess any correlation of serotypes to geographical ori-
gins, the dataset was grouped based on acquisition type and
infection site in order to remove any spurious relationship.
The groups were analyzed as described above; no statistically
significant correlation between serotypes or LPS core types
and geographical origin could be found. No significant cor-
relation of the presence of O1/O2 rfb cluster extended vari-
ant 2 to infection site, infection type or sample site was
found.
Association between serotype and virulence gene
content
Multiple virulence factors have been defined for Klebsiella
(Lawlor et al. 2007; Broberg et al. 2014) including three
siderophores (yersiniabactin, salmochelin and aerobactin),
the cytotoxin colibactin and rmpA/rmpA2, a regulator of
CPS overexpression (Cheng et al. 2010). Fimbrial adhesins
are also known to play a major role in biofilm formation
and are thus also classified as virulence factors. We deter-
mined if the distribution of these known virulence functions
was correlated with O- or K-serotype using the existing
global data set. The most noteable association was the sig-
nificant enrichment of an array of siderophore and colibac-
tin clusters and the mucosity regulator rmpA with K
serotypes K1 and K2 (Fig. 4a). Since K1 and K2 isolates
were almost exclusively also O1 serotypes, the same effect
was observed in O1. These results are perhaps unsurprising
given that these virulence genes are overrepresented in the
hypervirulent K. pneumoniae lineages, which are also
associated with serotypes K1 and K2 (Holt et al. 2015; Bia-
lek-Davenet et al. 2014).
Two types of fimbriae are known to be present in K. pneumo-
niae: type 1 and type 3 fimbriae. Whilst type 3 fimbriae are
known to bind to different human cell types, ranging from
tracheal epithelia to renal tubular cells, as well as being impor-
tant for binding to plants and abiotic surfaces (Khater et al.
2015), type 1 fimbriae appear more specific, so far they have
been shown to be important for adhesion to uroepithelial cells
and also for binding to plants (Klemm, Schembri 2000). Both
type 1 and type 3 fimbriae are also associated with biofilm for-
mation in K. pneumoniae (type 3 fimbriae more strongly than
type 1 (Schroll et al. 2010; Stahlhut et al. 2012; Klemm,
Schembri 2000). Our data showed that serotype O1 isolates
had a significantly higher likelihood of possessing type 1 fim-
briae compared with any other O serotype (odds ratio 9.7,
p=1.1E-16E-16E-1610–16, Fisher’s exact test) (Fig. 4b).
Differences in type 1 and type 3 fimbriae occurrence are very
pronounced between K1 and K2: whereas K1 lacks type 1 fim-
briae genes (none present, p=0.0019), K2 has a significantly
higher occurrence compared with any other K serotype (OR
15.8, p=3.8210–13); type 3 fimbriae genes are rarer in K1
(OR 0.03, p=6.4310–17) compared with any other K sero-
type. The majority of K1 isolates possessing neither type 1 nor
type 3 fimbriae (20 isolates without type 1 or type 3 fimbriae
out of a total of 35 K1 isolates), stem from a single sequence
type (ST82) present in the preantibiotic collection.
To further investigate the fact that K1 occurs almost exclu-
sively in community-acquired isolates and is absent in noso-
comial infections, a comparative genomic analysis was
performed to search for genes that are overrepresented in
K1 compared with other K-serotypes. Strikingly, an alginate
lyase isozyme was found to be present in all K1 isolates and
0%
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75%
100%
Sample site Acquisition Infection status
n=67 n=20 n=47 n=107 n=75 n=52 n=79 n=85
Blood Sputum Urine Community Nosocomi- Carriage Non-invasive Invasive
O serotype
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O3
O4
O5
O12
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other
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K16
K27
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K54
K62
K64
other
K23
Fig. 3. Distribution of serotypes in human K. pneumoniae isolates in the global collection. The eight most common O-types (left bars) and
ten most common K-types (right bars) are shown. Other serotypes are shown in dark grey.
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virtually absent in all other K serotypes (p=4.8210–57,
Fisher’s exact test). This K1-associated alginate lyase is
located just upstream of the thiamine pyrophosphate (TPP)
biosynthesis cluster (Fig. 4c). The only other commonly
occurring alginate lyase gene in the dataset was present
within the K14 cps cluster and has a sequence identity to the
K1 associated alginate lyase below 45 %. Alginate lyases
enable the use of alginate as carbon and energy source
(Wong et al. 2000).
Discussion
The rfb and cps gene clusters give rise to the dominant sero-
typical properties of K. pneumoniae and are therefore prior-
ity vaccine candidates for the treatment of this increasingly
multidrug-resistant pathogen. We have catalogued the natu-
rally occurring diversity of these gene clusters within a large
collection of isolates taken from different geographic and
clinical settings, hosts and disease manifestations. In doing
so we identified six known and five novel O-antigen clusters
and 45 known and 18 novel complete K-antigen biosynthe-
sis gene clusters. Of particular interest is a previously unde-
scribed rfb cluster (OL101), occurring in 5 % of isolates in
our dataset, originating in Europe, Asia and North America
and found in human, bovine and environmental samples.
We also identified a further 46 putative cps clusters (for
which only partial sequences could be obtained) which
appear novel. Although this may be an overestimate as
some of these may represent transposase variants or diver-
gent forms of other cps types or result from assembly errors;
additional work will be required to investigate and validate
these further.
This genetic catalogue of rfb and cps clusters enabled in silico
serotyping of whole genome sequences. We focused on the
seroepidemiology by analyzing the human-associated iso-
lates from the global dataset (Holt et al. 2015), where clini-
cal parameters such as infection site, type and acquisition
Table 2. Distribution of serotypes and LPS core types in human K. pneumoniae isolates in the global collection (n=216)
The eight most common O-types and ten most common K-types are shown. In the sample site category, samples from other than blood, urine or
sputum were excluded. In the acquisition mode category, samples where no acquisition mode was reported were excluded.
Sample site Acquisition Infectiousness
O serotype Blood
n=67
Urine
n=47
Sputum
n=20
Community
n=107
Nosocomial
n=75
Carriage
n=52
Infection
n=79
Invasive
n=85
O1 32 47.8 % 21 44.7 % 11 55.0 % 50 46.7 % 37 49.3 % 20 38.5 % 40 50.6 % 48 56.5 %
O2 10 14.9 % 9 19.1 % 2 10.0 % 14 13.1 % 10 13.3 % 5 9.6 % 13 16.5 % 10 11.8 %
O3 12 17.9 % 9 19.1 % 5 25.0 % 19 17.8 % 8 10.7 % 6 11.5 % 15 19.0 % 12 14.1 %
O4 5 7.5 % 2 4.3 % 0 0.0 % 3 2.8 % 3 4.0 % 0 0.0 % 2 2.5 % 5 5.9 %
O5 4 6.0 % 3 6.4 % 1 5.0 % 10 9.3 % 10 13.3 % 10 19.2 % 5 6.3 % 6 7.1 %
O12 2 3.0 % 1 2.1 % 0 0.0 % 4 3.7 % 1 1.3 % 2 3.8 % 1 1.3 % 2 2.4 %
OL101 1 1.5 % 0 0.0 % 1 5.0 % 4 3.7 % 2 2.7 % 5† 9.6 % 1 1.3 % 1 1.2 %
OL104 0 0.0 % 1 2.1 % 0 0.0 % 2 1.9 % 1 1.3 % 2 3.8 % 1 1.3 % 0 0.0 %
Others* 1 1.5 % 1 2.1 % 0 0.0 % 1 0.9 % 3 4.0 % 2 3.8 % 1 1.3 % 1 1.2 %
K serotype
K1 3 4.5 % 2 4.3 % 2 10.0 % 11 10.3 % 1 1.3 % 0 0.0 % 6 7.6 % 8 9.4 %
K2 9 13.4 % 3 6.4 % 1 5.0 % 8 7.5 % 3 4.0 % 1 1.9 % 4 5.1 % 12† 14.1 %
K5 2 3.0 % 1 2.1 % 0 0.0 % 3 2.8 % 1 1.3 % 0 0.0 % 2 2.5 % 2 2.4 %
K16 3 4.5 % 1 2.1 % 0 0.0 % 2 1.9 % 2 2.7 % 0 0.0 % 1 1.3 % 3 3.5 %
K23 0 0.0 % 0 0.0 % 0 0.0 % 1 0.9 % 3 4.0 % 3 5.8 % 1 1.3 % 0 0.0 %
K27 2 3.0 % 2 4.3 % 0 0.0 % 2 1.9 % 0 0.0 % 0 0.0 % 2 2.5 % 2 2.4 %
K28 2 3.0 % 2 4.3 % 0 0.0 % 3 2.8 % 2 2.7 % 1 1.9 % 2 2.5 % 2 2.4 %
K54 0 0.0 % 3 6.4 % 0 0.0 % 2 1.9 % 2 2.7 % 1 1.9 % 3 3.8 % 0 0.0 %
K62 3 4.5 % 0 0.0 % 0 0.0 % 2 1.9 % 2 2.7 % 2 3.8 % 0 0.0 % 4 4.7 %
K64 3 4.5 % 1 2.1 % 3 15.0 % 6 5.6 % 6 8.0 % 4 7.7 % 5 6.3 % 3 3.5 %
Others* 40 59.7 % 32 68.1 % 14 70.0 % 67 62.6 % 53 70.7 % 40 76.9 % 53 67.1 % 49 57.6 %
LPS core type
Type 1 43 64.2 % 35 74.5 % 12 60.0 % 68 63.6 % 55 73.3 % 37 71.2 % 55 69.6 % 55 64.7 %
Type 2 7 10.4 % 3 6.4 % 2 10.0 % 9 8.4 % 10 13.3 % 7 13.5 % 7 8.9 % 11 12.9 %
Others* 17 25.4 % 9 19.1 % 6 30.0 % 30 28.0 % 10 13.3 % 8 15.4 % 17 21.5 % 19 22.4 %
* Unidentified or not listed † Significant correlation (see text)
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mode have been recorded. We showed that O serotypes O1,
O2 and O3 accounted for 80 % or more of all samples
included in this study and that the relative prevalence of
these O serotypes was approximately the same for all infec-
tion sites, infection types and acquisition modes. This con-
trasted with the K serotypes, for which an order of
magnitude higher diversity was found and no single K sero-
type dominated this collection.
Notable in the K serotype analysis was the distribution of
serotype K1 sequences: most K1 isolates in our study
belong to one of two lineages, ST23 and ST82 and showed
a strong association with community-acquired infections,
consistent with previous reports and the known association
of ST23 with the hypervirulent phenotype (Tsay et al.
2002; Yu et al. 2007). K1 isolates were found in six out of
seven countries covered by our genome collection. How-
ever, despite the fact that K1 is regarded as one of the two
most common serotypes it was only found once in 162 iso-
lates collected over a period of seven years in a UK hospital
(this study) and is absent in another study based on 703
isolates in 13 hospitals located in Western Europe and
Northern America (Cryz et al. 1986). This contrasts with
reports from Taiwan, China and South Africa where K1
appears to have been dominant for a considerable period
of time (Fung et al. 2000,2002; Yu et al. 2007; Peng et al.
1991; Luo 1990) and has been associated with compara-
tively higher prevalence of hypervirulent infections in
these countries, mostly linked to the ST23 lineage (Bialek-
Davenet et al. 2014).
When looking for genes closely associated with K1 we iden-
tified the presence of a gene predicted to encode an alginate
lyase isozyme. Outside of K1 the only other alginate lyase
detected is distantly related and part of the K14 cps cluster.
Hence, this gene is almost exclusively found in isolates of
the K1 serotype (including those of both major K1 lineages).
Pseudomonas aeruginosa is known to produce alginate dur-
ing biofilm biogenesis in chronic lung infections of cystic
fibrosis patients. Alginate lyase enables cell detachment
from the biofilm (Boyd & Chakrabarty 1995; Ramsey &
Wozniak 2005). However it is not known whether K. pneu-
moniae produces alginate biofilms. Moreover, since it is
unusual to find alginate-lyase-producers, like the K1 K.
pneumoniae, that do not use alginate as primary carbon
source, it has been proposed that alginate lyase production
could be related to coinfection of P. aeruginosa and K. pneu-
moniae in cystic fibrosis patients (Wong et al. 2000). Given
the above it is suggested that the association with cystic
fibrosis is important, but probably it is opportunistic, and
its role in K. pneumoniae is much broader.
We found no association of LPS core type with the isolates’
infection sites, infection types and acquisition modes. This
is in contrast to a study showing that LPS core type 2 con-
tributes to the level of virulence in K. pneumoniae, although
its mechanism is so far unknown (Regué et al. 2005).
Virulence genes (siderophores, colibactin, rmpA and fim-
briae) are expected to be overrepresented in isolates from
infections compared with those from carriage or environ-
mental sources and are particularly overrepresented in
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lineages associated with hypervirulent invasive disease (Holt
et al. 2015), thus the significantly high presence in K. pneu-
moniae serotype O1 isolates was anticipated. However, their
significantly lower abundance in isolates of serotype O2 or
O3, which are both also prevalent in human infection, was
more surprising.
The striking difference in the distribution of the two major
fimbriae types found in K. pneumoniae is also of note. Type
3 fimbriae are essential for biofilm formation (Schroll et al.
2010), while type 1 fimbriae are important for adhesion to
uroepithelial cells and are thus considered virulence factors
for urinary tract infection (Stahlhut et al. 2012). The differ-
ential distribution of fimbriae in K. pneumoniae
probably allows isolates to adhere to different receptors and
perhaps exploit or specialize in different niches, the pres-
ence of type 1 fimbriae in K2 isolates and the notable
absence of type 1 fimbriae in K1 isolates is intriguing but
will require more targeted sampling to unravel its true bio-
logical significance.
It is suspected that certain CPS types are able to influence
the accessibility of the LPS O-antigen, possibly masking it;
the reports are however inconclusive: Hsieh et al. (2012)
described the masking of the O1 antigen by K1 capsule but
not by K2, whereas Szijártó et al. (2015) showed that the O1
antigen is accessible by antibodies irrespective of the capsule
type. The potential masking of O-antigen by the capsule
warrants further research and is the crucial next step
towards a polysaccharide-based vaccine against K. pneumo-
niae infection.
Our data indicate that O and K serotypes are frequently re-
assorted within the K. pneumoniae population. There are far
fewer distinct O serotypes than K serotypes but among the
O serotypes, those that are most common are generally
associated with a higher number of distinct K serotypes.
While there are lineage-specific clustering effects (Fig. 2),
these data support the hypothesis that the rfb and/or cps
clusters are shuffled within the K. pneumoniae population
via horizontal gene transfer. However given the wide diver-
sity of K serotypes, much larger strain collections will need
to be examined in order to detect a statistically significant
divergence from random re-assortment of CPS and LPS
loci.
K. pneumoniae is considered to be a significant threat to
human health with the rates of infection increasing globally
and appearing to be driven by increasing levels of antimi-
crobial resistance to front line antimicrobials. The short-
term solution has been to turn to old drugs such as colistin
that are associated with significant nephrotoxicity. However,
the development of resistance to colistin is rapid and
explained by both intrinsic mechanisms, such as point
mutations (Cheng et al. 2015), as well as by the acquisition
of genes by lateral gene transfer (Liu et al. 2015). With this
in mind we found that O-serotype prevalence and distribu-
tion were stable with regards to different infection types and
sites. In addition although O serotype switching has been a
common occurrence in the evolution of K. pneumoniae K
serotypes show a much bigger variance (Wyres et al. 2015).
Consequently O antigens, defined in detail in this study,
offer a promising target for vaccine design that warrant fur-
ther research.
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